Rare diseases
Investigational molecules
Locations
Back to the Netherlands1 919 clinical trials in Leidschendam, The Netherlands across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in the NetherlandsKlinischOnderzoek.nl(opens in a new tab)Study on Zanubrutinib for Patients with Primary Cold Agglutinin Disease
The NetherlandsStudy on Burfiralimab for Patients with Moderate to Severe Rheumatoid Arthritis
The NetherlandsStudy of VRDN-001 for Patients with Thyroid Eye Disease Who Did Not Respond to Previous Treatment
The NetherlandsStudy on Tisotumab Vedotin, Bevacizumab, Carboplatin, and Pembrolizumab for Patients with Recurrent or Stage IVB Cervical Cancer
The NetherlandsStudy on Long-Term Safety of Donidalorsen for Patients with Hereditary Angioedema
The NetherlandsLong-Term Study of BI 1015550 for Patients with Idiopathic Pulmonary Fibrosis and Progressive Pulmonary Fibrosis
The NetherlandsStudy on Hyperbaric Oxygen Therapy for Acute Hamstring Injury in Athletes and Military Personnel
The NetherlandsStudy on Esketamine for Long-term Pain Relief in Patients with Complex Regional Pain Syndrome
The NetherlandsStudy of [177Lu]Lu-NeoB and Capecitabine for Patients with Advanced Breast Cancer Resistant to Hormone Therapy
The NetherlandsStudy on the Effectiveness and Safety of OTL-203 for Patients with Hurler Syndrome (MPS-IH) Compared to Standard Treatment with Stem Cell Transplantation
The NetherlandsStudy of Tucatinib, Trastuzumab, and Pertuzumab for Patients with Advanced or Metastatic HER2+ Breast Cancer
The NetherlandsStudy of Datopotamab Deruxtecan and Pembrolizumab for Patients with Advanced or Metastatic Non-small Cell Lung Cancer Without Actionable Genomic Alterations
The NetherlandsThe busiest research cities in the country
What the registry says about research in the country
Multiple clinical trials focusing on non-small cell lung cancer (NSCLC) treatment advancements, evaluating novel therapeutic approaches including immunotherapy combinations and targeted treatments.
Studies compare various treatment options to improve patient outcomes and survival rates.
Comprehensive research into breast cancer treatments, particularly focusing on hormone receptor-positive and HER2-positive subtypes, investigating targeted therapies and chemotherapy combinations.
Trials examine innovative treatment strategies and personalized approaches.
Studies focusing on lymphoma treatments, including both Hodgkin and non-Hodgkin variants, evaluating response-adapted therapies and novel drug combinations.
Research aims to improve treatment outcomes while minimizing toxicity.
Investigations into colorectal cancer and related conditions, including innovative surgical approaches and treatment strategies for recurrent disease.
Focus on improving surgical outcomes and treatment effectiveness.
Studies examining treatment options for cerebral radiation necrosis and brain metastases, including innovative detection methods and therapeutic approaches.
Research aims to improve detection and treatment of brain metastases.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
